SCHEMBL6949798

SCHEMBL6949798

Cc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1C(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.41
HTT P42858 4/20 0.40
NPSR1 Q6W5P4 3/20 0.40
POLB P06746 3/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 7/20 0.39
KDM4E B2RXH2 6/20 0.39
HPGD P15428 6/20 0.39
MAPT P10636 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HSD17B10 Q99714 2/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
AKT1 P31749 3/20 0.35
AKT2 P31751 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953953 0.83 GRM2 (0.41) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6949302 0.83 GRM2 (0.43) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6949656 0.82 GRM2 (0.41) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6947212 0.82 HPGD (0.41) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6951651 0.82 HPGD (0.43) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6952709 0.81 GRM2 (0.42) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6947600 0.81 GRM2 (0.40) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6951472 0.80 ALDH1A1 (0.47) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6945471 0.80 HPGD (0.42) GRM2HTTNPSR1POLBRAB9A
SCHEMBL6947753 0.80 GAA (0.41) GRM2HTTNPSR1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed